Buprenorphine + Naloxone Injection Suppliers & Bulk Manufacturers
Available Forms: Injection
Available Strengths: 0.3 mg/mL, 0.6 mg/mL, 1 mg/mL
Reference Brands: Buprenex(US)
Category:
Analgesic
Buprenorphine + Naloxone injection activates mu-opioid receptors, relieving severe pain, while Naloxone blocks opioid effects if injected illicitly, reducing misuse potential. Benefits include rapid, effective pain relief, opioid dependency management, and decreased overdose risk when used responsibly. Suitable for hospital or clinical pain management.
Buprenorphine + Naloxone Injection is available in Injection
and strengths such as 0.3 mg/mL, 0.6 mg/mL, 1 mg/mL.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Buprenorphine + Naloxone Injection is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Buprenorphine + Naloxone Injection can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Buprenorphine + Naloxone injection is approved in the US and EU for opioid dependence treatment, primarily used in clinical settings. In the US, brands like Sublocade are regulated by the FDA, supported by comprehensive dossiers demonstrating safety, efficacy, and manufacturing quality. In the EU, approval by EMA involves extensive dossiers, clinical data, and pharmacovigilance commitments. Due to high abuse potential, strict prescribing regulations and monitoring are enforced in both regions. For expert assistance with regulatory dossiers, compliance, and registration, visit PharmaTradz. We support seamless market access for buprenorphine + naloxone injection, ensuring adherence to European and US standards for safe, effective opioid dependency treatment.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing